Delays in coccidioidomycosis diagnosis and associated healthcare utilization, Tucson, Arizona, USA

Fariba M. Donovan, Patrick Wightman, Yue Zong, Luke Gabe, Aneela Majeed, Tiffany Ynosencio, Edward J. Bedrick, John N. Galgiani

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Tucson, Arizona, USA, is a highly coccidioidomycosis-endemic area. We conducted a retrospective review of 815 patients in Tucson over 2.7 years. Of 276 patients with coccidioidomycosis, 246 had a delay in diagnosis; median delay was 23 days. Diagnosis delay was associated with coccidioidomycosis-related costs totaling $589,053 and included extensive antibacterial drug use.

Original languageEnglish (US)
Pages (from-to)1745-1747
Number of pages3
JournalEmerging infectious diseases
Volume25
Issue number9
DOIs
StatePublished - Jan 1 2019

Fingerprint

Coccidioidomycosis
Delivery of Health Care
Costs and Cost Analysis
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Epidemiology
  • Microbiology (medical)
  • Infectious Diseases

Cite this

Delays in coccidioidomycosis diagnosis and associated healthcare utilization, Tucson, Arizona, USA. / Donovan, Fariba M.; Wightman, Patrick; Zong, Yue; Gabe, Luke; Majeed, Aneela; Ynosencio, Tiffany; Bedrick, Edward J.; Galgiani, John N.

In: Emerging infectious diseases, Vol. 25, No. 9, 01.01.2019, p. 1745-1747.

Research output: Contribution to journalArticle

Donovan, Fariba M. ; Wightman, Patrick ; Zong, Yue ; Gabe, Luke ; Majeed, Aneela ; Ynosencio, Tiffany ; Bedrick, Edward J. ; Galgiani, John N. / Delays in coccidioidomycosis diagnosis and associated healthcare utilization, Tucson, Arizona, USA. In: Emerging infectious diseases. 2019 ; Vol. 25, No. 9. pp. 1745-1747.
@article{5c819d001d7741618a4a5a0ae406e20c,
title = "Delays in coccidioidomycosis diagnosis and associated healthcare utilization, Tucson, Arizona, USA",
abstract = "Tucson, Arizona, USA, is a highly coccidioidomycosis-endemic area. We conducted a retrospective review of 815 patients in Tucson over 2.7 years. Of 276 patients with coccidioidomycosis, 246 had a delay in diagnosis; median delay was 23 days. Diagnosis delay was associated with coccidioidomycosis-related costs totaling $589,053 and included extensive antibacterial drug use.",
author = "Donovan, {Fariba M.} and Patrick Wightman and Yue Zong and Luke Gabe and Aneela Majeed and Tiffany Ynosencio and Bedrick, {Edward J.} and Galgiani, {John N.}",
year = "2019",
month = "1",
day = "1",
doi = "10.3201/eid2509.190023",
language = "English (US)",
volume = "25",
pages = "1745--1747",
journal = "Emerging Infectious Diseases",
issn = "1080-6040",
publisher = "Centers for Disease Control and Prevention (CDC)",
number = "9",

}

TY - JOUR

T1 - Delays in coccidioidomycosis diagnosis and associated healthcare utilization, Tucson, Arizona, USA

AU - Donovan, Fariba M.

AU - Wightman, Patrick

AU - Zong, Yue

AU - Gabe, Luke

AU - Majeed, Aneela

AU - Ynosencio, Tiffany

AU - Bedrick, Edward J.

AU - Galgiani, John N.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Tucson, Arizona, USA, is a highly coccidioidomycosis-endemic area. We conducted a retrospective review of 815 patients in Tucson over 2.7 years. Of 276 patients with coccidioidomycosis, 246 had a delay in diagnosis; median delay was 23 days. Diagnosis delay was associated with coccidioidomycosis-related costs totaling $589,053 and included extensive antibacterial drug use.

AB - Tucson, Arizona, USA, is a highly coccidioidomycosis-endemic area. We conducted a retrospective review of 815 patients in Tucson over 2.7 years. Of 276 patients with coccidioidomycosis, 246 had a delay in diagnosis; median delay was 23 days. Diagnosis delay was associated with coccidioidomycosis-related costs totaling $589,053 and included extensive antibacterial drug use.

UR - http://www.scopus.com/inward/record.url?scp=85071500016&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071500016&partnerID=8YFLogxK

U2 - 10.3201/eid2509.190023

DO - 10.3201/eid2509.190023

M3 - Article

C2 - 31441755

AN - SCOPUS:85071500016

VL - 25

SP - 1745

EP - 1747

JO - Emerging Infectious Diseases

JF - Emerging Infectious Diseases

SN - 1080-6040

IS - 9

ER -